Active ingredientLorazepamCat. No. P-L093-001CAS 846-49-1Family · Pharmaceutical analytical standards
Lorazepam
A benzodiazepine patented in 1963 and first marketed in the US in 1977: it is used for anxiety, severe agitation, seizures such as status epilepticus and as premedication. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?The liver inactivates it by simple conjugation with glucuronic acid, without needing to oxidise it: the product, lorazepam glucuronide, is pharmacologically inactive.
Go to the active ingredient →Active ingredientLorazepamCat. No. P-L093-001CAS 846-49-1
Pharmacopoeial impurityLorazepam EP Impurity ACat. No. P-L093-002CAS 2958-36-3
Pharmacopoeial impurityLorazepam EP Impurity BCat. No. P-L093-003CAS 2848-96-6
Pharmacopoeial impurityLorazepam EP Impurity CCat. No. P-L093-004CAS 2955-37-5
Pharmacopoeial impurityLorazepam EP Impurity DCat. No. P-L093-005CAS 54699-91-1
Pharmacopoeial impurityLorazepam EP Impurity ECat. No. P-L093-006CAS 93955-15-8
Pharmacopoeial impurityLorazepam USP Related Compound DCat. No. P-L093-007CAS 54643-79-7
Pharmacopoeial impurityLorazepam USP Related Compound ECat. No. P-L093-008CAS 773871-49-1
ImpurityLorazepam Impurity 1Cat. No. P-L093-009CAS 23441-87-4
ImpurityLorazepam Impurity 2 HydrochlorideCat. No. P-L093-010
ImpurityLorazepam Impurity 3Cat. No. P-L093-011CAS 52335-37-2No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceLorazepam CRSEDQM code L0750500Family LorazepamImpurityLorazepam impurity D CRSEDQM code Y0000718Family LorazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.